Showing results (131-140 of 279) with videos related to
Sort By:
Pageof 28
Cancer Cell|July 5, 2008
In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell propertiesChristoph le Viseur, Marc Hotfilder, Simon Bomken, et al.Cell Death and Differentiation|December 24, 2016
RSK-mediated nuclear accumulation of the cold-shock Y-box protein-1 controls proliferation of T cells and T-ALL blastsSteffi Gieseler-Halbach, Stefan Meltendorf, Mandy Pierau, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk groupCornelia Eckert, Günter Henze, Karlheinz Seeger, et al.Blood|May 8, 2013
Leukemia surfaceome analysis reveals new disease-associated featuresPaulina Mirkowska, Andreas Hofmann, Lukasz Sedek, et al.Blood|October 16, 2004
The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95Wilhelm Woessmann, Kathrin Seidemann, Georg Mann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2008
Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trialsAndishe Attarbaschi, Georg Mann, Renate Panzer-Grümayer, et al.Leukemia|December 12, 2022
Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009Thomas Lehrnbecher, Andreas H Groll, Simone Cesaro, et al.The Lancet. Oncology|August 18, 2012
Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup studyAndrea Biondi, Martin Schrappe, Paola De Lorenzo, et al.Blood Advances|January 14, 2025
Subclonal TP53 and KRAS variants combined with poor treatment response identify ultrahigh-risk pediatric patients with T-ALLTamara Kempter, Paulina Richter-Pechańska, Katarzyna Michel, et al.Genes, Chromosomes & Cancer|August 31, 2004
Emergence of translocation t(9;11)-positive leukemia during treatment of childhood acute lymphoblastic leukemiaMarkus Metzler, Pamela L Strissel, Reiner Strick, et al.Pageof 28